In this episode of RhAPPcast, the official podcast of Rheumatology Advanced Practice Providers, host Amanda Mixon, PA-C, is joined by Jessica Glennie, CNP, as they discuss key interstitial lung disease (ILD) updates from the 2026 EULAR Congress in the first episode of a special three-part RhAPP Up series.

They explore the healthcare and financial impact of connective tissue disease-associated ILD (CTD-ILD), highlighting why early diagnosis and treatment are so important for improving patient outcomes and reducing long-term costs. The episode also reviews emerging research on a potential new therapy for systemic sclerosis that may target multiple aspects of the disease and help slow its progression.

Whether you're a rheumatology provider, advanced practice provider (APP), or other healthcare professional, this episode provides practical insights into the latest ILD research, evolving treatment strategies, and the value of early, multidisciplinary care.

Stay tuned for Part 2 and visit the Content Rheum to stay up to date with the latest clinical insights in rheumatologic care.